TY  - JOUR
AU  - Pachon-Ibañez, Maria E
AU  - Labrador-Herrera, Gema
AU  - Cebrero-Cangueiro, Tania
AU  - Diaz, Caridad
AU  - Smani, Younes
AU  - Del-Palacio, Jose P
AU  - Rodriguez-Baño, Jesus
AU  - Pascual, Alvaro
AU  - Pachon, Jeronimo
AU  - Conejo, M Carmen
PY  - 2018
DO  - 10.3389/fmicb.2018.00912
SN  - 1664-302X
UR  - http://hdl.handle.net/10668/12547
T2  - Frontiers in microbiology
AB  - Despite the relevance of carbapenemase-producing Klebsiella pneumoniae (CP-Kp) infections there are a scarce number of studies to evaluate in vivo the efficacy of combinations therapies. The bactericidal activity of colistin, rifampin, and its...
LA  - en
PB  - Frontiers Research Foundation
KW  - Klebsiella pneumoniae
KW  - animal models
KW  - carbapenemase producers
KW  - colistin
KW  - rifampin
KW  - Animals
KW  - Colistin
KW  - carbapenemase
KW  - Rifampin
KW  - Klebsiella pneumoniae
KW  - beta-Lactamases
KW  - Sepsis
KW  - Pneumonia
TI  - Efficacy of Colistin and Its Combination With Rifampin in Vitro and in Experimental Models of Infection Caused by Carbapenemase-Producing Clinical Isolates of Klebsiella pneumoniae.
TY  - research article
VL  - 9
ER  -